Prognosis of autoimmune hepatitis showing acute presentation

Hepatology Research

Volumn 43, Issue 6, 2013, Pages 630-638

  Yamamoto, Kazuhide ^a   Miyake, Yasuhiro ^a   Ohira, Hiromasa ^b   Suzuki, Yoshiyuki ^c   Zeniya, Mikio ^d   Onji, Morikazu ^e   Tsubouchi, Hirohito ^f   Yoshizawa, Kaname ^g   Morizane, Toshio ^h   Hibi, Toshifumi ⁱ   Aoyagi, Yutaka ^j   Nakanuma, Yasuni ^k   Hirohara, Junko ^l   Takikawa, Hajime ^m   Ishibashi, Hiromi ⁿ   Shimoda, Shinji ^o   Sakisaka, Shotaro ^p   Nakamuta, Makoto ^q   Matsuzaki, Yasushi ^r   Saibara, Toshiji ^s   Ueno, Yoshiyuki ^t   Miyakawa, Hiroshi ^u   Kokudo, Norihiro ^v   Egawa, Hiroto ^w   Maehara, Yoshihiko ^x   Mochida, Satoshi ^y   Sakaida, Isao ^z   Fujisawa, Tomoo ^aa   Suzuki, Kazuyuki ^ab   Inoue, Kazuaki ^ac   Ichida, Takafumi ^ad   Yokosuka, Osamu ^ae   Fukui, Hiroshi ^af   Moriwaki, Hisataka ^ag   Mori, Mitsuru ^ah   Mori, Toshiyuki ^ai   Nagino, Masato ^aj   Sata, Naohiro ^ak   Tazuma, Susumu ^al   Yasaka, Takahiro ^am   Tsuyuguchi, Toshio ^ae   Shoda, Junichi ^an   Honda, Masao ^l   Yamaue, Hiroki ^ao   Unno, Michiaki ^u   Hayashi, Norio ^ap   more..

^a OKAYAMA UNIVERSITY   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^c TORANOMON HOSPITAL   (Japan)

^d JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f KAGOSHIMA UNIVERSITY   (Japan)

^g SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^j KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^l KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^m KANSAI MEDICAL UNIVERSITY   (Japan)

ⁿ TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^o NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^p KYUSHU UNIVERSITY   (Japan)

^q FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^r NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

^s TOKYO MEDICAL UNIVERSITY   (Japan)

^t KOCHI MEDICAL SCHOOL   (Japan)

^u TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^v TEIKYO UNIVERSITY MIZONOKUCHI HOSPITAL   (Japan)

^w UNIVERSITY OF TOKYO   (Japan)

^x Murakami Memorial Hospital   (Japan)

^y SAITAMA MEDICAL UNIVERSITY   (Japan)

^z YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^aa SAISEIKAI YOKOHAMASHI TOBU HOSPITAL   (Japan)

^ab IWATE MEDICAL UNIVERSITY   (Japan)

^ac SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

^ad JUNTENDO UNIVERSITY SHIZUOKA HOSPITAL   (Japan)

^ae CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^af NARA MEDICAL UNIVERSITY   (Japan)

^ag GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^ah SAPPORO MEDICAL UNIVERSITY   (Japan)

^ai KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^aj NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^ak JICHI MEDICAL UNIVERSITY   (Japan)

^al HIROSHIMA UNIVERSITY   (Japan)

^am Kamigoto Hospital   (Japan)

^an UNIVERSITY OF TSUKUBA   (Japan)

^ao WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^ap OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

Acute presentation; Autoimmune hepatitis; Prothrombin activity; Prothrombin time international normalized ratio; Pulse steroid treatment

Indexed keywords

ANTINUCLEAR ANTIBODY; BILIRUBIN; GLYCYRRHIZIC ACID; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; PREDNISOLONE; PROTHROMBIN; SMOOTH MUSCLE ANTIBODY; URSODEOXYCHOLIC ACID;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; BACTERIAL INFECTION; BILIRUBIN BLOOD LEVEL; BONE NECROSIS; CORTICOSTEROID THERAPY; DEATH; DIABETES MELLITUS; DRUG PULSE THERAPY; FEMALE; HISTOPATHOLOGY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOGLOBULIN BLOOD LEVEL; INTERNATIONAL NORMALIZED RATIO; LIVER HISTOLOGY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MYCOSIS; OSTEOPOROSIS; PNEUMOCYSTOSIS; PRIORITY JOURNAL; PROGNOSIS; PROTHROMBIN TIME; QUESTIONNAIRE;

EID: 84878781342     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2012.01109.x     Document Type: Article

References (19)

1. Waldenström J. Leber, blutproteine und nahrungseiweisse. Dtsch Ges Verd Stoffw 1950; 15: 113-119.
2. Krawitt EL. Autoimmune hepatitis. N Engl J Med 1996; 334: 897-903.
3. Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993; 18: 998-1005.
4. Alvarez F, Berg PA, Bianchi FB etal. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-938.
5. Hennes EM, Zeniya M, Czaja AJ etal. International Autoimmune Hepatitis Group. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008; 48: 169-176.
6. Toda G, Zeniya M, Watanabe F etal. Present status of autoimmune hepatitis in Japan - correlating the characteristics with international criteria in an area with a high rate of HCV infection. Japanese National Study Group of Autoimmune Hepatitis. J Hepatol 1997; 26: 1207-1212.
7. Abe M, Mashiba T, Zeniya M, Yamamoto K, Onji M, Tsubouchi H, Autoimmune Hepatitis Study Group-Subgroup of the Intractable Hepato-Biliary Disease Study Group in Japan. Present status of autoimmune hepatitis in Japan: a nationwide survey. J Gastroenterol 2011; 46: 1136-1141.
8. Nikias GA, Batts KP, Czaja AJ. The nature and prognostic implications of autoimmune hepatitis with an acute presentation. J Hepatol 1994; 21: 866-871.
9. Abe M, Onji M, Kawai-Ninomiya K etal. Clinicopathologic features of the severe form of acute type 1 autoimmune hepatitis. Clin Gastroenterol Hepatol 2007; 5: 255-258.
10. Kessler WR, Cummings OW, Eckert G, Chalasani N, Lumeng L, Kwo PY. Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis. Clin Gastroenterol Hepatol 2004; 2: 625-631.
11. Ichai P, Duclos-Vallée JC, Guettier C etal. Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis. Liver Transpl 2007; 13: 996-1003.
12. Onji M, Autoimmune Hepatitis Study Group. Proposal of autoimmune hepatitis presenting with acute hepatitis, severe hepatitis and acute liver failure. Hepatol Res 2011; 41: 497.
13. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29-36.
14. Miyake Y, Iwasaki Y, Kobashi H etal. Autoimmune hepatitis with acute presentation in Japan. Dig Liver Dis 2010; 42: 51-54.
15. Onji M, Nonaka T, Horiike N, Moriwaki H, Muto Y, Ohta Y. Present status of autoimmune hepatitis in Japan. Gastroenterol Jpn 1993; 28 (Suppl 4): 134-138.
16. Mochida S, Takikawa Y, Nakayama N etal. Diagnostic criteria of acute liver failure: a report by the Intractable Hepato-Biliary Diseases Study Group of Japan. Hepatol Res 2011; 41: 805-812.
17. Lee WM. Acute liver failure in the United States. Semin Liver Dis 2003; 23: 217-226.
18. Czaja AJ. Genetic factors affecting the occurrence, clinical phenotype, and outcome of autoimmune hepatitis. Clin Gastroenterol Hepatol 2008; 6: 379-388.
19. Zeitlin AA, Heward JM, Newby PR etal. Analysis of HLA class II genes in Hashimoto's thyroiditis reveals differences compared to Graves' disease. Genes Immun 2008; 9: 358-363.